TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25342100

Group type: EXPERIMENTAL
Intervention: Acupuncture at five real acupoints (PC6, SP6, HT7, KI6, and BL62) used unilaterally in turn, treated three times during the first week.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Intradermal acupuncture (IDA) performed continuously on the subject's skin, stimulated at home every night.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham acupuncture at five sham acupoints over 1 cm away from each real acupoint.
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham acupuncture points provided by STRICTA.
Number of subjects: 38
Study: 23659181

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 2.5 or 5 mg/kg (DEX 1)
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: Dexibuprofen 3.5 or 7 mg/kg (DEX 2)
Number of subjects: 264

Group type: COMPARATOR
Intervention: Ibuprofen 5 or 10 mg/kg (control)
Number of subjects: 264
Study: 20033066

Group type: EXPERIMENTAL
Intervention: IL-12 plasmid/lipopolymer complexes (phIL-12/PPC) at doses of 0.6, 3, 12 or 24 mg m(‐2) once every week for 4 weeks
Number of subjects: 13
Study: 17949514

Group type: EXPERIMENTAL
Intervention: Nicotine gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 16810572

Group type: EXPERIMENTAL
Intervention: LocaLisa mapping system
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional ablation technique
Number of subjects: 56
Study: 12753337

Group type: EXPERIMENTAL
Intervention: Interferon alpha (IFN) administered as 10 MU QD or TIW for 4 weeks, followed by 5 MU QD or TIW for 20 weeks, and then by 3 MU QD or TIW for 24 weeks, in combination with ribavirin (1.0-1.2 g/day)
Number of subjects: 142
Study: 11164321

Group type: EXPERIMENTAL
Intervention: Videotaped information
Number of subjects: 30

Group type: COMPARATOR
Intervention: Detailed written information
Number of subjects: 30
Study: 9737555

Group type: EXPERIMENTAL
Intervention: Sodium reduction
Number of subjects: 744

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 744
Study: 7930412

Group type: EXPERIMENTAL
Intervention: Valproate treatment
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Reduction of valproate dose
Number of subjects: 306
Study: 3265156

Group type: EXPERIMENTAL
Intervention: Corticosteroids (intravenous methylprednisolone or oral prednisone) at a standard dose of 80 mg/day for 5 days or variable doses of 20-120 mg/day for 4-20 days, along with trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Corticosteroids (intravenous methylprednisolone or oral prednisone)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group (no steroids)
Number of subjects: 33
Study: 31061156

Group type: EXPERIMENTAL
Intervention: LYS228 (multiple intravenous doses)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (multiple intravenous doses)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: LYS228 (single and multiple intravenous doses)
Number of subjects: 100
Study: 27476066

Group type: EXPERIMENTAL
Intervention: Hand held dynamometry (HHD) with a portable stabilization device
Number of subjects: 15
Study: 25932618

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Memantine + Constraint-Induced Aphasia Therapy (CIAT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28

Group type: COMPARATOR
Intervention: Healthy group
Number of subjects: 28
Study: 24280475

Group type: EXPERIMENTAL
Intervention: Laughing Qigong Program (LQP)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control (reading or doing homework)
Number of subjects: 67
Study: 21691756

Group type: EXPERIMENTAL
Intervention: Diabetes management programme (DMP) 'Therapie aktiv'
Number of subjects: 1489

Group type: EXPERIMENTAL
Intervention: Antidiabetic medication (oral antidiabetics, insulin, or both)
Number of subjects: 1489

Group type: EXPERIMENTAL
Intervention: Antihypertensive medication
Number of subjects: 1489

Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 1489

Group type: EXPERIMENTAL
Intervention: Overall quality of care
Number of subjects: 1489
Study: 19112586

Group type: EXPERIMENTAL
Intervention: Parthenolide-depleted Feverfew (PD-Feverfew)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole Feverfew
Number of subjects: 0
Study: 16945893

Group type: EXPERIMENTAL
Intervention: Fiber-reinforced composite (FRC) substructures (short random and continuous bidirectional fiber orientation) with a surface layer of PFC
Number of subjects: 8

Group type: COMPARATOR
Intervention: Plain particulate filler composite (PFC)
Number of subjects: 8
Study: 15265246

Group type: EXPERIMENTAL
Intervention: Quetiapine 150-750 mg/day
Number of subjects: 620

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 620
Study: 11734864

Group type: EXPERIMENTAL
Intervention: Radiosurgery plus WBRT
Number of subjects: 100

Group type: COMPARATOR
Intervention: WBRT alone
Number of subjects: 100
Study: 9402380

Group type: EXPERIMENTAL
Intervention: Brompheniramine (12 mg) administered at 8:00 A.M. and 8:00 P.M. for ≤ 4 days after onset of symptoms
Number of subjects: 113
Study: 8425662

Group type: EXPERIMENTAL
Intervention: High insulin infusion (3056 +/‐ 236 pM)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Low insulin infusion (486 +/‐ 33 pM)
Number of subjects: 9
Study: 30612529

Group type: EXPERIMENTAL
Intervention: Pedometer-based physically active learning intervention (n = 52)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Pedometer-based physically active learning intervention
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (n = 31)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Low Active pupils in the intervention
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Most Active pupils in the intervention
Number of subjects: 154
Study: 30298673

Group type: EXPERIMENTAL
Intervention: Combined antioxidant treatment (vitamins, antioxidants, and oligoelements) for six months
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 27323611

Group type: EXPERIMENTAL
Intervention: Tongxinluo Capsule (TC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 80
Study: 24777981

Group type: EXPERIMENTAL
Intervention: Flaxseed (30 g of milled flaxseed/d for 6 months)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: α-linolenic acid (from flaxseed)
Number of subjects: 0
Study: 22456619

Group type: COMPARATOR
Intervention: Vitamin D(2), 2,000 IU daily for 6 weeks (arm A, control)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Vitamin D(3), 2,000 IU daily for 6 weeks (arm B)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Vitamin D(2), 50,000 IU weekly for 6 weeks (arm C)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: All arms
Number of subjects: 71
Study: 20600512

Group type: EXPERIMENTAL
Intervention: 40 mcg HBV vaccine with 250 mcg GM-CSF
Number of subjects: 48

Group type: COMPARATOR
Intervention: 40 mcg HBV vaccine without GM-CSF (control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: GM-CSF as an adjuvant
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Overall response based on CD4 count
Number of subjects: 48
Study: 18241137

Group type: EXPERIMENTAL
Intervention: Heart and Soul Physical Activity Program (HSPAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 0
Study: 15987669

Group type: EXPERIMENTAL
Intervention: Drug-naïve patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conventionally treated patients (haloperidol or fluphenazine)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Atypically treated patients (olanzapine)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: All patient groups
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Conventionally treated patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Atypically and conventionally treated patients
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Drug-naïve and treated patients
Number of subjects: 80
Study: 12453256

Group type: EXPERIMENTAL
Intervention: Resin modified glass-ionomer (Vitremer)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Composite resin (Z100)
Number of subjects: 24
Study: 9920948

Group type: EXPERIMENTAL
Intervention: Etanercept (25 mg) plus methotrexate
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo plus methotrexate
Number of subjects: 89
Study: 9208666

Group type: EXPERIMENTAL
Intervention: Madopar treatment (26 amblyopia eyes)
Number of subjects: 314

Group type: COMPARATOR
Intervention: Amblyopia eyes (108 amblyopia eyes)
Number of subjects: 314
Study: 2127054

Group type: EXPERIMENTAL
Intervention: Recombinant alpha‐interferon
Number of subjects: 115
Study: 7356903

Group type: EXPERIMENTAL
Intervention: 400 mg cimetidine with 250 mg tetracycline tablets
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo with 250 mg tetracycline tablets
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 400 mg cimetidine 8 hourly for 6 days with 500 mg tetracycline as tablets
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo with 500 mg tetracycline as suspension
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Cimetidine treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Tetracycline tablets and suspension
Number of subjects: 6
Study: 30820770

Group type: EXPERIMENTAL
Intervention: Imagined event files
Number of subjects: 0

Group type: COMPARATOR
Intervention: Perceived event files
Number of subjects: 0
Study: 29511316

Group type: EXPERIMENTAL
Intervention: n-back training with strategy instruction
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: n-back training without strategy instruction
Number of subjects: 116

Group type: COMPARATOR
Intervention: Passive controls
Number of subjects: 116
Study: 26227922

Group type: EXPERIMENTAL
Intervention: Peri-articular injections (PAI)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 80
Study: 24668608

Group type: EXPERIMENTAL
Intervention: 10% glucose solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: 0.05% aspartame solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: 9.0% maltodextrin solution
Number of subjects: 12

Group type: COMPARATOR
Intervention: water
Number of subjects: 12
Study: 22928884

Group type: EXPERIMENTAL
Intervention: 30% oral glucose
Number of subjects: 11

Group type: COMPARATOR
Intervention: Nothing (control)
Number of subjects: 11
Study: 20350322

Group type: EXPERIMENTAL
Intervention: Combined diabetes knowledge/information and motivation/behavioral skills training intervention
Number of subjects: 232

Group type: COMPARATOR
Intervention: Usual care/general health education group
Number of subjects: 232
Study: 17885013

Group type: EXPERIMENTAL
Intervention: Telephone counseling intervention group
Number of subjects: 3088
Study: 15987428

Group type: EXPERIMENTAL
Intervention: Estrogen therapy (1 mg/day of micronized 17beta‐estradiol)
Number of subjects: 232

Group type: EXPERIMENTAL
Intervention: Combined estrogen and progestin therapy (17beta‐estradiol and 5 mg/day of medroxyprogesterone acetate for 12 days/month)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 232
Study: 12085073

Group type: EXPERIMENTAL
Intervention: Structured skills-based intervention (4-hour didactic, video, and skills-based workshop)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 36
Study: 9464197

Group type: EXPERIMENTAL
Intervention: Short REM latency in relatives of depressed probands with short REM latency
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Lifetime risk of depression in relatives of depressed probands with short REM latency
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Polysomnographic abnormalities in unaffected relatives
Number of subjects: 252
Study: 7842768

Group type: EXPERIMENTAL
Intervention: 40 micrograms ipratropium bromide plus 200 micrograms salbutamol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 80 micrograms ipratropium bromide plus 400 micrograms salbutamol
Number of subjects: 26

Group type: COMPARATOR
Intervention: 80 micrograms ipratropium bromide
Number of subjects: 26

Group type: COMPARATOR
Intervention: 40 micrograms ipratropium bromide
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: 200 micrograms salbutamol and 40 micrograms ipratropium bromide
Number of subjects: 26
Study: 2404204

Group type: EXPERIMENTAL
Intervention: Azathioprine (2.5 mg per kilogram of body weight per day)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 361408

Group type: EXPERIMENTAL
Intervention: L-dopa
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 31806052

Group type: EXPERIMENTAL
Intervention: Compression therapy (group A)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No compression (group B)
Number of subjects: 0
Study: 29369237

Group type: EXPERIMENTAL
Intervention: sEGD
Number of subjects: 201

Group type: COMPARATOR
Intervention: huTNE
Number of subjects: 201

Group type: COMPARATOR
Intervention: muTNE
Number of subjects: 201
Study: 27697943

Group type: EXPERIMENTAL
Intervention: Intervention group (Smoke Free Homes Program)
Number of subjects: 508

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 508
Study: 24946646

Group type: EXPERIMENTAL
Intervention: Assisted-electroacupuncture
Number of subjects: 80
Study: 22000747

Group type: EXPERIMENTAL
Intervention: Neoadjuvant radiochemotherapy with radiation doses of 50.4 Gy combined with 5-fluorouracil-based chemotherapy
Number of subjects: 163
Study: 20153888

Group type: EXPERIMENTAL
Intervention: Acyclovir 400 mg orally twice daily
Number of subjects: 3381

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3381
Study: 17284556

Group type: EXPERIMENTAL
Intervention: High baseline resilience (low burden, high care demands)
Number of subjects: 1979
Study: 16184258

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12722936

Group type: EXPERIMENTAL
Intervention: 8 adjunctive hypnosis sessions targeting accelerated wound healing
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 8 adjunctive supportive attention sessions
Number of subjects: 18

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 18
Study: 10802311

Group type: EXPERIMENTAL
Intervention: CS-insulin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CS-glucose
Number of subjects: 0

Group type: COMPARATOR
Intervention: CS-placebo
Number of subjects: 0
Study: 8894569

Group type: EXPERIMENTAL
Intervention: Imipenem plus vancomycin
Number of subjects: 407

Group type: COMPARATOR
Intervention: Cefoperazone-sulbactam plus vancomycin
Number of subjects: 407
Study: 1643679

Group type: EXPERIMENTAL
Intervention: meperidine 0.25 mg.kg‐1
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: meperidine 0.5 mg.kg‐1
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: pancuronium 0.06 mg.kg‐1 intravenously
Number of subjects: 61

Group type: COMPARATOR
Intervention: shivering group
Number of subjects: 61
Study: 6426931

Group type: EXPERIMENTAL
Intervention: 60 mg valerian (1 capsule Harmonicum Much)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 120 mg valerian (2 capsules Harmonicum Much)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 30941800

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet (low in processed carbohydrates and animal proteins, rich in omega-3 fatty acids, vitamin C, vitamin D, antioxidants, plant nitrates, and fibres for 4 weeks)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Anti-inflammatory diet
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no dietary change)
Number of subjects: 30
Study: 28940840

Group type: EXPERIMENTAL
Intervention: LY2963016 (LY IGlar) at 0.3 U/kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: LY2963016 (LY IGlar) at 0.6 U/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lantus (IGlar) at 0.3 U/kg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lantus (IGlar) at 0.6 U/kg
Number of subjects: 24
Study: 26575111

Group type: EXPERIMENTAL
Intervention: LNG-IUS + low-dose transdermal estradiol (TDE) gel (0.06% containing 0.75 mg of TDE, administered once daily for 50 days)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: LNG-IUS + low-dose transdermal estradiol (TDE) gel
Number of subjects: 38

Group type: COMPARATOR
Intervention: LNG-IUS alone (control)
Number of subjects: 38
Study: 25185362

Group type: EXPERIMENTAL
Intervention: Yiqibushenhuoxue decoction plus Seretide
Number of subjects: 70

Group type: COMPARATOR
Intervention: Seretide only
Number of subjects: 70
Study: 21111754

Group type: EXPERIMENTAL
Intervention: Intervention based on the Health Behavior Framework
Number of subjects: 432
Study: 19578018

Group type: EXPERIMENTAL
Intervention: Vitrectomy for idiopathic unilateral macular hole
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Baseline interocular disparities lower than 0.35 degrees at 1 degree eccentricity
Number of subjects: 42
Study: 17409778

Group type: EXPERIMENTAL
Intervention: Perichondrium/cartilage island flap technique using full-thickness cartilage disk
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Perichondrium/cartilage island flap technique using bisected cartilage to half of its thickness
Number of subjects: 0
Study: 15048552

Group type: EXPERIMENTAL
Intervention: Lactate
Number of subjects: 8

Group type: COMPARATOR
Intervention: Bicarbonate
Number of subjects: 8
Study: 12814339

Group type: EXPERIMENTAL
Intervention: Calcipotriol + acitretin combination therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Acitretin monotherapy
Number of subjects: 60
Study: 9664948

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 33

Group type: COMPARATOR
Intervention: Cyclosporine
Number of subjects: 33
Study: 8018618

Group type: EXPERIMENTAL
Intervention: Goserelin (GnRH-agonist)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 2501801

Group type: EXPERIMENTAL
Intervention: Flupenthixol dihydrochloride (1 to 2 mg/day)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Fluvoxamine maleate (100 to 200 mg/day)
Number of subjects: 72
Study: 576832

Group type: EXPERIMENTAL
Intervention: Reproterol (Bronchospasmin) - i.v. 60 and 90 mug, single peroral administration of 20 mg, long-term therapy with 60 mg in either 3 or 6 daily doses
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 30794310

Group type: EXPERIMENTAL
Intervention: Nadir epiglottic pressure during respiratory events in NREM stage 2 sleep terminated with arousals
Number of subjects: 31
Study: 28755774

Group type: EXPERIMENTAL
Intervention: Motivational computer intervention (MAPIT)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: In-person motivational interviewing (MI)
Number of subjects: 316

Group type: COMPARATOR
Intervention: Standard probation intake (SAU)
Number of subjects: 316

Group type: EXPERIMENTAL
Intervention: Substance use
Number of subjects: 316
Study: 26318552

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation of the calf muscles for 1 hour session twice daily for the first postoperative week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Current standard of care (control group)
Number of subjects: 40
Study: 24492904

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: General Supportive Intervention
Number of subjects: 32

Group type: COMPARATOR
Intervention: No Treatment (Control)
Number of subjects: 32
Study: 21788224

Group type: EXPERIMENTAL
Intervention: Pagibaximab 90 mg/kg
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Pagibaximab 60 mg/kg
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 19470769

Group type: EXPERIMENTAL
Intervention: Chronomodulated infusion of 5-fluorouracil, leucovorin, and oxaliplatin
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional infusion of 5-fluorouracil, leucovorin, and oxaliplatin
Number of subjects: 130
Study: 16753318

Group type: EXPERIMENTAL
Intervention: Nebulized N-acetylcysteine (NAC)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 19
Study: 15269349

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic antagonist propranolol administered at encoding
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional verbal stimuli
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neutral verbal stimuli
Number of subjects: 0
Study: 11677004

Group type: EXPERIMENTAL
Intervention: Moderate daily exercise program (n=14)
Number of subjects: 25

Group type: COMPARATOR
Intervention: No physical activity beyond usual daily requirements (n=11)
Number of subjects: 25
Study: 9919444

Group type: EXPERIMENTAL
Intervention: Fast-tracking
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control (no fast-tracking)
Number of subjects: 217
Study: 8050232

Group type: EXPERIMENTAL
Intervention: Posterior cruciate ligament retained knee
Number of subjects: 28

Group type: COMPARATOR
Intervention: Posterior cruciate ligament excised knee
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Stair activity (ascend/descend with one leg at a time)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Stair activity (using each leg in sequence)
Number of subjects: 28
Study: 1867167

Group type: EXPERIMENTAL
Intervention: 38% phosphoric acid gel for 60 seconds
Number of subjects: 40

Group type: COMPARATOR
Intervention: 60% phosphoric acid gel with 0.5% sodium fluoride for 60 seconds
Number of subjects: 40
Study: 418745

Group type: EXPERIMENTAL
Intervention: 12.5 mg diethylcarbamazine daily for five months
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 25 mg diethylcarbamazine daily for five months
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 12.5 mg diethylcarbamazine daily for seven weeks
Number of subjects: 88
Study: 30381997

Group type: EXPERIMENTAL
Intervention: Bilateral rTMS (4000 left‐sided excitatory pulses, 1000 right‐sided inhibitory pulses) for 20 sessions
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 15
Study: 27842954

Group type: EXPERIMENTAL
Intervention: Lateral wedge insole (6 mm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (without lateral wedge insole)
Number of subjects: 20
Study: 26034151

Group type: EXPERIMENTAL
Intervention: Etanercept 25 mg once weekly
Number of subjects: 59

Group type: COMPARATOR
Intervention: Etanercept 50 mg once weekly
Number of subjects: 59